Tetragenex Pharmaceuticals, Inc.
Records under this name other than patents Tetragenex Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Tetragenex Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,797,897 | Timer Lapsed on the fee record Ended Sep 28, 2012 · Medium confidence | Lapsed on the fee record | Ended Sep 28, 2012 | Medium confidence |
| US 6,767,897 | Therapeutic uses of tri-, tetra-, penta-, and polypeptides Lapsed on the fee record Ended Jul 27, 2012 · USPTO record | Lapsed on the fee record | Ended Jul 27, 2012 | USPTO record |
| US 6,093,797 | Tri-, Tetra-, Penta-, and polypeptides and their therapeutic use as an antidepressant agent Lapsed on the fee record Ended Jul 25, 2012 · USPTO record | Lapsed on the fee record | Ended Jul 25, 2012 | USPTO record |
| US 7,214,669 | Tetracycline derivatives and methods of use thereof Lapsed on the fee record Ended May 8, 2011 · USPTO record | Lapsed on the fee record | Ended May 8, 2011 | USPTO record |
| US 5,589,460 | Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent Term ended Term ended no later than Dec 31, 2016 · Low confidence | Term ended | Term ended no later than Dec 31, 2016 | Low confidence |
| US 5,721,207 | Method for treatment of pain Term ended Term ended no later than Feb 24, 2018 · Low confidence | Term ended | Term ended no later than Feb 24, 2018 | Low confidence |
| US 5,767,083 | Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent Term ended Term ended no later than Jun 16, 2018 · Low confidence | Term ended | Term ended no later than Jun 16, 2018 | Low confidence |
| US 5,840,683 | Peptides inhibiting the oncogenic action of p21 ras Term ended Term ended no later than Nov 24, 2018 · Low confidence | Term ended | Term ended no later than Nov 24, 2018 | Low confidence |
| US 5,910,478 | Peptidomimetics inhibiting the oncogenic action of p21 ras Term ended Term ended no later than Jun 8, 2019 · Low confidence | Term ended | Term ended no later than Jun 8, 2019 | Low confidence |
| US 5,990,172 | Peptidomimetics for the treatment of HIV infection Term ended Term ended no later than Nov 23, 2019 · Low confidence | Term ended | Term ended no later than Nov 23, 2019 | Low confidence |